Bayer Cropscience Limited
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance… Read more
Bayer Cropscience Limited (BAYERCROP) - Net Assets
Latest net assets as of September 2025: ₹31.23 Billion INR
Based on the latest financial reports, Bayer Cropscience Limited (BAYERCROP) has net assets worth ₹31.23 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹51.91 Billion) and total liabilities (₹20.68 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹31.23 Billion |
| % of Total Assets | 60.17% |
| Annual Growth Rate | 12.46% |
| 5-Year Change | 11.77% |
| 10-Year Change | 62.33% |
| Growth Volatility | 31.54 |
Bayer Cropscience Limited - Net Assets Trend (2004–2025)
This chart illustrates how Bayer Cropscience Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bayer Cropscience Limited (2004–2025)
The table below shows the annual net assets of Bayer Cropscience Limited from 2004 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹28.50 Billion | +0.04% |
| 2024-03-31 | ₹28.49 Billion | +5.06% |
| 2023-03-31 | ₹27.12 Billion | +7.44% |
| 2022-03-31 | ₹25.24 Billion | -1.02% |
| 2021-03-31 | ₹25.50 Billion | -0.86% |
| 2020-03-31 | ₹25.73 Billion | +36.59% |
| 2019-03-31 | ₹18.83 Billion | +5.91% |
| 2018-03-31 | ₹17.78 Billion | -13.54% |
| 2017-03-31 | ₹20.57 Billion | +17.13% |
| 2016-03-31 | ₹17.56 Billion | -13.63% |
| 2015-03-31 | ₹20.33 Billion | +16.68% |
| 2014-03-31 | ₹17.42 Billion | -9.79% |
| 2013-03-31 | ₹19.31 Billion | +143.64% |
| 2012-03-31 | ₹7.93 Billion | +17.79% |
| 2011-03-31 | ₹6.73 Billion | +20.22% |
| 2010-03-31 | ₹5.60 Billion | +24.13% |
| 2009-03-31 | ₹4.51 Billion | +22.07% |
| 2008-03-31 | ₹3.69 Billion | +11.47% |
| 2007-03-31 | ₹3.31 Billion | 0.00% |
| 2006-03-31 | ₹3.31 Billion | +28.25% |
| 2005-03-31 | ₹2.58 Billion | +6.80% |
| 2004-03-31 | ₹2.42 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bayer Cropscience Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1753.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹23.08 Billion | 80.97% |
| Common Stock | ₹449.00 Million | 1.58% |
| Other Comprehensive Income | ₹3.58 Billion | 12.56% |
| Other Components | ₹1.39 Billion | 4.89% |
| Total Equity | ₹28.50 Billion | 100.00% |
Bayer Cropscience Limited Competitors by Market Cap
The table below lists competitors of Bayer Cropscience Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Semitronix Corp. A
SHE:301095
|
$984.90 Million |
|
COFCO Capital Holdings Co Ltd
SHE:002423
|
$985.29 Million |
|
Redde Northgate PLC
F:21W
|
$985.84 Million |
|
Kunshan Kersen Science & Tech
SHG:603626
|
$986.15 Million |
|
Faw Car Co Ltd
SHE:000800
|
$984.75 Million |
|
MFA Financial Inc
NYSE:MFA
|
$984.59 Million |
|
Teladoc Inc
NYSE:TDOC
|
$984.48 Million |
|
T1 Energy Inc.
NYSE:TE
|
$983.80 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bayer Cropscience Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 28,494,000,000 to 28,504,000,000, a change of 10,000,000 (0.0%).
- Net income of 5,680,000,000 contributed positively to equity growth.
- Dividend payments of 5,608,000,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹5.68 Billion | +19.93% |
| Dividends Paid | ₹5.61 Billion | -19.67% |
| Other Changes | ₹-62.00 Million | -0.22% |
| Total Change | ₹- | 0.04% |
Book Value vs Market Value Analysis
This analysis compares Bayer Cropscience Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.08x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 55.69x to 7.08x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-03-31 | ₹80.58 | ₹4487.60 | x |
| 2005-03-31 | ₹65.43 | ₹4487.60 | x |
| 2006-03-31 | ₹83.91 | ₹4487.60 | x |
| 2007-03-31 | ₹83.91 | ₹4487.60 | x |
| 2008-03-31 | ₹93.53 | ₹4487.60 | x |
| 2009-03-31 | ₹114.17 | ₹4487.60 | x |
| 2010-03-31 | ₹141.72 | ₹4487.60 | x |
| 2011-03-31 | ₹170.38 | ₹4487.60 | x |
| 2012-03-31 | ₹200.69 | ₹4487.60 | x |
| 2013-03-31 | ₹488.95 | ₹4487.60 | x |
| 2014-03-31 | ₹475.79 | ₹4487.60 | x |
| 2015-03-31 | ₹555.15 | ₹4487.60 | x |
| 2016-03-31 | ₹486.72 | ₹4487.60 | x |
| 2017-03-31 | ₹581.74 | ₹4487.60 | x |
| 2018-03-31 | ₹510.55 | ₹4487.60 | x |
| 2019-03-31 | ₹438.35 | ₹4487.60 | x |
| 2020-03-31 | ₹572.40 | ₹4487.60 | x |
| 2021-03-31 | ₹567.46 | ₹4487.60 | x |
| 2022-03-31 | ₹561.68 | ₹4487.60 | x |
| 2023-03-31 | ₹603.47 | ₹4487.60 | x |
| 2024-03-31 | ₹634.02 | ₹4487.60 | x |
| 2025-03-31 | ₹634.24 | ₹4487.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bayer Cropscience Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 19.93%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.38%
- • Asset Turnover: 1.04x
- • Equity Multiplier: 1.84x
- Recent ROE (19.93%) is below the historical average (20.83%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 14.57% | 4.15% | 1.18x | 2.97x | ₹110.59 Million |
| 2005 | 10.20% | 3.65% | 1.26x | 2.22x | ₹5.18 Million |
| 2006 | 17.16% | 7.81% | 1.10x | 1.99x | ₹237.15 Million |
| 2007 | 17.16% | 7.81% | 1.10x | 1.99x | ₹237.15 Million |
| 2008 | 13.29% | 4.22% | 1.36x | 2.31x | ₹121.58 Million |
| 2009 | 20.95% | 6.78% | 1.49x | 2.08x | ₹493.63 Million |
| 2010 | 22.73% | 7.83% | 1.50x | 1.93x | ₹712.74 Million |
| 2011 | 19.55% | 6.45% | 1.30x | 2.34x | ₹642.47 Million |
| 2012 | 17.54% | 6.31% | 1.20x | 2.32x | ₹597.30 Million |
| 2013 | 60.15% | 42.63% | 1.13x | 1.25x | ₹9.69 Billion |
| 2014 | 21.98% | 10.29% | 1.56x | 1.37x | ₹2.09 Billion |
| 2015 | 18.84% | 10.29% | 1.34x | 1.36x | ₹1.80 Billion |
| 2016 | 17.95% | 11.32% | 1.14x | 1.39x | ₹1.40 Billion |
| 2017 | 14.15% | 10.34% | 1.00x | 1.37x | ₹853.30 Million |
| 2018 | 16.88% | 11.05% | 1.07x | 1.43x | ₹1.22 Billion |
| 2019 | 17.90% | 10.62% | 1.09x | 1.54x | ₹1.49 Billion |
| 2020 | 18.45% | 13.15% | 0.94x | 1.49x | ₹2.17 Billion |
| 2021 | 19.33% | 11.57% | 1.01x | 1.66x | ₹2.38 Billion |
| 2022 | 25.56% | 13.63% | 1.09x | 1.72x | ₹3.93 Billion |
| 2023 | 27.96% | 14.75% | 1.10x | 1.73x | ₹4.87 Billion |
| 2024 | 25.99% | 14.50% | 1.11x | 1.61x | ₹4.56 Billion |
| 2025 | 19.93% | 10.38% | 1.04x | 1.84x | ₹2.83 Billion |
Industry Comparison
This section compares Bayer Cropscience Limited's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $3,847,635,393
- Average return on equity (ROE) among peers: 8.50%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bayer Cropscience Limited (BAYERCROP) | ₹31.23 Billion | 14.57% | 0.66x | $984.78 Million |
| Agro Phos India Limited (AGROPHOS) | $520.47 Million | 9.61% | 1.50x | $4.15 Million |
| Aries Agro Limited (ARIES) | $1.81 Billion | 7.52% | 1.37x | $31.60 Million |
| Astec LifeSciences Limited (ASTEC) | $1.35 Billion | 10.91% | 1.68x | $35.37 Million |
| Best Agrolife Limited (BESTAGRO) | $577.23 Million | 0.02% | 0.90x | $20.16 Million |
| Bhagiradha Chemicals & Industries Limited (BHAGCHEM) | $461.53 Million | -6.95% | 2.88x | $102.33 Million |
| Bharat Rasayan Limited (BHARATRAS) | $437.35 Million | 13.47% | 0.48x | $65.75 Million |
| Bohra Industries Limited (BOHRAIND) | $568.54 Million | -4.53% | 0.07x | $2.29 Million |
| Bombay Super Hybrid Seeds Limited (BSHSL) | $1.05 Billion | 25.22% | 1.12x | $24.86 Million |
| Chambal Fertilizers & Chemicals Limited (CHAMBLFERT) | $27.85 Billion | 21.19% | 4.00x | $752.16 Million |